Evaluation of the difference in clinical manifestations of chronic obstructive pulmonary disease between men and women: an analytical cross-sectional study
DOI:
https://doi.org/10.11606/issn.1679-9836.v101i2e-188656Keywords:
COPD, Gender, Women, Chronic obstructive pulmonary diseaseAbstract
Introduction: Despite being a typically male disease, the prevalence of COPD in women has been rising. Therefore, it’s very important to know its clinical presentation among groups, so the correct clinical approach can be planned. Objectives: Evaluate the difference in COPD symptoms, as well as its impact and the associated risk factors, between men and women. Methodology: Analytical, observational and cross-sectional study where 203 COPD patients were evaluated. Spirometric diagnosis was the most relevant inclusion criteria. A descriptive analysis was stratified between gender and non parametric tests were realized. COPD Assessment Test (CAT), Charlson Comorbidity Index and FRAIL-BR were applied and used to compare genders. Results: The impact of symptoms using the COPD Assessment Test (CAT) was higher in women (p=0,04) and clinically significant. Conclusion: Women with COPD are more symptomatic.
Downloads
References
Global Initiative for Chronic Obstructive Lung Disease. Fontana, WI, USA; 2020. Available from: www.goldcopd.org.
Ferrari R, Tanni SE, Lucheta PA, Faganello MM, Antonialli R, Godoy I. Preditores do estado de saúde em pacientes com DPOC de acordo com o gênero. J Bras Pneumol. 2010;36(1):37-43. doi: 10.1590/S1806-37132010000100008.
Gu SY, Deng XJ, Li QY, Sun XW, Xu JF, Li HP. Gender differences of chronic obstructive pulmonary disease associated with manifestations on HRCT. Clin Respir J. 2017;11(1):28–35. doi: 10.1111/crj.12297.
Jia G, Lu M, Wu R, Chen Y, Yao W. Gender difference on the knowledge, attitude, and practice of COPD diagnosis and treatment: A national, multicenter, cross-sectional survey in China. Int J COPD. 2018;13:3269-80. doi: 10.2147/COPD.S176173.
Lisspers K, Larsson K, Janson C, Ställberg B, Tsiligianni I, Gutzwiller FS, et al. Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study. NPJ Prim Care Respir Med. 2019;29(1):1-8. http://dx.doi.org/10.1038/s41533-019-0157-3.
Almagro P, López García F, Cabrera F, Montero L, Morchón D, Díez J, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med. 2010;104(2):253-9. doi: 10.1016/j.rmed.2009.09.019.
Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585-96. doi: 10.1016/S2213-2600(20)30105-3.
Rabahi MF. Epidemiologia da DPOC: enfrentando desafios. Pulmão RJ. 2013;4-8. http://repositorio.bc.ufg.br/handle/ri/17374.
Ntritsos G, Franek J, Belbasis L, Christou MA, Markozannes G, Altman P, et al. Gender-specific estimates of COPD prevalence: A systematic review and meta-analysis. Int J COPD. 2018;13:1507-14. doi: 10.2147/COPD.S146390.
Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease: the impact of gender. Curr Opin Pulm Med. 2017;23(2):117-23. doi: 10.1097/MCP.0000000000000353.
Jenkins CR, Chapman KR, Donohue JF, Roche N, Tsiligianni I, Han MLK. Improving the management of COPD in women. Chest. 2017;151(3):686-96. doi: 10.1016/j.chest.2016.10.031.
Gut-Gobert C, Cavaillès A, Dixmier A, Guillot S, Jouneau S, Leroyer C, et al. Women and COPD: do we need more evidence? Eur Respir Rev. 2019;28(151). http://dx.doi.org/10.1183/16000617.0055-2018.
Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: Are women more susceptible to smoking effects than men? Thorax. 2010;65(6):480-5. doi: 10.1136/thx.2009.122002.
Barnes PJ. Sex differences in chronic obstructive pulmonary disease mechanisms. Am J Respir Crit Care Med. 2016;193(8):813-24. doi: 10.1164/rccm.201512-2379ED.
DeMeo DL, Ramagopalan S, Kavati A, Vegesna A, Han MK, Yadao A, et al. Women manifest more severe COPD symptoms across the life course. Int J COPD. 2018;13:3021-9. doi: 10.2147/COPD.S160270.
Martinez CH, Raparla S, Plauschinat CA, Giardino ND, Rogers B, Beresford J, et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt). 2012;21(12):1267-74. doi: 10.1089/jwh.2012.3650.
Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007;176(3):243-52. doi: 10.1164/rccm.200606-828OC.
Dias LS. Avaliação da fragilidade em pacientes com doença pulmonar obstrutiva crônica [dissertação]. Goiânia, GO: Universidade Federal de Goiás; 2020. p.14-5. Disponível em http://repositorio.bc.ufg.br/tede/handle/tede/10832.
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54. doi: 10.1183/09031936.00102509.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373-83. doi: 10.1016/0021-9681(87)90171-8.
Fabrício-Wehbe SCC, Cruz IR, Haas VJ, Diniz MA, Dantas RAS, Rodrigues RAP. Reprodutibilidade da versão Brasileira adaptada da Edmonton Frail Scale para idosos residentes na comunidade. Rev Latino-Am Enfermagem. 2013;21(6):1330-6. doi: 10.1590/0104-1169.2933.2371.
Veras RP, Ramos LR, Kalache A. Crescimento da população idosa no Brasil: transformações e consequências na sociedade. Rev Saúde Pública. 1987;21(3):225-33. doi: 10.1590/S0034-89101987000300007.
Lombardi EMS, Prado GF, Santos U de P, Fernandes FLA. O tabagismo e a mulher: riscos, impactos e desafios. J Bras Pneumol. 2011;37(1):118-28. doi: 10.1590/S1806-37132011000100017.
Kon SSC, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195-203. doi: 10.1016/S2213-2600(14)70001-3
Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results front a Danish Longitudinal Population Study. Eur Respir J. 1997;10(4):822-7. doi: 10.1183/09031936.97.10040822.
Nunes E. Consumo de tabaco. Efeitos na saúde. Rev Port Med Geral Fam. 2006;22:225-44. doi: 10.32385/rpmgf.v22i2.10231.
Araújo AJ. Tratamento do tabagismo pode impactar a DPOC. Pulmão RJ. 2009;1(1):20-33.
Reis AP, Stirbulov R. Síndrome de sobreposição asma e DPOC. Arq Asma Alerg Imunol. 2017;1(2):189-94. doi: 10.5935/2526-5393.20170022.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Giovanna Guilherme Barcelos, Isabella Ribeiro de Sena Carvalho, Mariana Alves Santana de Araújo, Anna Carolina Galvão Ferreira, Marcelo Fouad Rabahi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
